Constructive Bio is pushing the boundaries of synthetic biology, and Benchling has been a key partner in this journey. Their platform helps us manage complex data and streamline workflows as we scale genome writing and engineered translation. Learn how we’re pioneering the future of biology:
Discover how Constructive Bio is building beyond nature to create the next generation of biomolecules. Using synthetic genomes and non-canonical amino acids, this UK-based biotech is developing therapeutics with enhanced molecular and chemical properties. Just look at drugs like Wegovy and Ozempic — their active ingredient semaglutide incorporates a non-canonical amino acid to improve drug stability. Now imagine how this technology will expand the toolkit available not only for drug development, but across industries. With Constructive’s ability to design molecules with unprecedented specificity and fidelity, they’re unlocking the next generation of biologics — and doing so in a more sustainable and scalable way. See how they’re using Benchling to centralize their data and scale their R&D. We’re proud to support their mission! 🧬🧑🔬 https://lnkd.in/emjEFqAz #BuiltOnBenchling
